ANIK anikatherapeutics.com: Market Value to Book Value Ratio
Anika Therapeutics (ANIK) maintains pricing power in the joint segment through its unique hyaluronate injections, while sterile automated production lines ensure flawless product quality supported by qualified specialists. This price chart captures the indicator at 2.10. Anika Therapeutics is advancing regenerative medicine, gradually expanding its portfolio of viscoelastic agents and tissue implants for body restoration.
Analytical breakdowns and data insights for company Anika Therapeutics (ANIK)
- market value and analyst target forecast:
- company stock capitalization data:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Anika Therapeutics|ANIK - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital anikatherapeutics.com|ANIK - Company Total Debt Obligations|Debts to Book Capitalization Anika|ANIK - Company Long-Term Debts|Company Short-Term Debt Anika Therapeutics|Quick Ratio anikatherapeutics.com
- earnings and market multiples details:
Analysis of all company metrics:Anika Therapeutics Inc. - ANIK
This ratio reflects the gap between investor market expectations and the actual net asset value of Anika Therapeutics (ANIK), which specializes in the supply of hyaluronic products for sports medicine. By analyzing the historical market-to-book value ratio, one can assess the degree of business overvaluation relative to its balance sheet, which helps determine the resilience of quotes to liquidity outflows.
Competitor analysis
Boston Scientific (BSX) - Market Value to Book Value Ratio|edwards.com (EW) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Tandem Corp (TNDM)|AXGN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets SIBN|OFIX: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bioventus Inc (BVS)|KIDS (OrthoPediatrics Corp) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio TMCI (Treace Corp)|Market Cap to Net Assets Ratio SRTA (Strata Critical Medical Inc)|CARL (carlsmed.com) - Market Value to Book Value|Market Value to Book Value Ratio RxSight RXST|CLPT - Market Cap to Net Assets Ratio|Stereotaxis Corp - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Neuronetics, Inc|SGHT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio OBIO|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Jin Medical International Ltd (ZJYL) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.